Nav: Home

New gene therapy for pseudarthrosis trialed at Kazan University

December 02, 2016

A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation. The combination was highly effective in a patient admitted to the Republican Clinical Hospital in Kazan, Russia. The treatment was approved by the ethical committee, supported by the Ministry of Healthcare of Tatarstan and published in BioNanoScience.

Professor Rizvanov explains: «We combined a demineralized bone transplant with recombinant genetic material, which carries genes for vascular endothelial growth factor, to stimulate new blood vessel growth (angiogenesis), and bone morphogenetic protein to stimulate bone growth (osteogenesis). Thus survival of transplant and bone tissue formation was achieved at the desired location. We were able to translate our basic and pre-clinical research and are the first to document the efficacy of such therapy in a real clinical case of pseudarthrosis».

As the team leader noted, for a long time clinicians have tried standard methods of bone regeneration - osteosynthesis and osteoplasty - when an absent bone part is replaced with allogenic, cadaveric or demineralized bone matrix. In the latter case cells and minerals are removed from an animal bone tissue, and only the matrix is left - a "bone-like sponge" that can be used to fill in defects in the bone to stimulate formation of a new bone. However, current procedures often result in complications, such as resorption of the transplant. Parts of the problem are poor blood supply and low levels of pro-osteogenic growth factors.

Our therapy, a combination of demineralized bone with gene therapy, is a promising solution for the currently existing complication problems in pseudarthrosis and other bone defects and fracture treatments. We now plan to offer such innovative treatments at the Kazan University Clinic as a part of a new clinical trial program at strategic academic unit Translational 7P Medicine for biomedical and translational research.
-end-


Kazan Federal University

Related Gene Therapy Articles:

Mysterious gene transcripts after cancer therapy
Drugs that are used in cancer therapy to erase epigenetic alterations in cancer cells simultaneously promote the production of countless mysterious gene transcripts, scientists from the German Cancer Research Center now report in Nature Genetics.
Gene therapy could 'turn off' severe allergies
A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.
Lipid nanoparticles for gene therapy
Twenty-five years have passed since the publication of the first work on solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as a system for delivering drugs.
New gene therapy for pseudarthrosis trialed at Kazan University
A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation.
WSU researcher develops safer gene therapy
A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy.
New gene therapy prevents muscle wasting associated with cancer
A new gene therapy could be used to prevent the loss of muscle mass and physical strength associated with advanced cancer
On the path to controlled gene therapy
The ability to switch disease-causing genes on and off remains a dream for many physicians, research scientists and patients.
Gene therapy against brain cancer
A team from the International School for Advanced Studies (SISSA) in Trieste has obtained very promising results by applying gene therapy to glioblastoma.
First gene therapy successful against human aging
Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully rejuvenated by gene therapy, after her own company's experimental therapies reversed 20 years of normal telomere shortening.
Designing gene therapy
Scientists in the Barabas group at EMBL have increased the efficiency of a genome-engineering tool called Sleeping Beauty, which is showing promise in clinical trials for leukemia and lymphoma immunotherapies.

Related Gene Therapy Reading:

The Gene: An Intimate History
by Siddhartha Mukherjee (Author)

Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology: Principles, Delivery and Pharmacological and Biomedical Applications of ... (Icp Textbooks in Biomolecular Sciences)
by Daniel Scherman (Editor)

Gene Therapy, An Issue of Hematology/Oncology Clinics of North America (The Clinics: Internal Medicine)
by Daniel E. Bauer MD PhD (Author), Donald B Kohn MD (Author)

Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fourth Edition
by Nancy Smyth Templeton (Editor)

The Gene Therapy Plan: Taking Control of Your Genetic Destiny with Diet and Lifestyle
by Mitchell L. Gaynor MD (Author), Mehmet C. Oz M.D. (Foreword)

Gene Therapy in Neurological Disorders
by Mingjie Li (Editor), B. Joy Snider (Editor)

The Forever Fix: Gene Therapy and the Boy Who Saved It
by Ricki Lewis (Author)

Adenoviral Vectors for Gene Therapy
by David T. Curiel (Editor)

GUIDE TO HUMAN GENE THERAPY, A
by Roland W Herzog (Editor), Sergei Zolotukhin (Editor)

Gene therapy
by The Open University

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Hacking The Law
We have a vision of justice as blind, impartial, and fair — but in reality, the law often fails those who need it most. This hour, TED speakers explore radical ways to change the legal system. Guests include lawyer and social justice advocate Robin Steinberg, animal rights lawyer Steven Wise, political activist Brett Hennig, and lawyer and social entrepreneur Vivek Maru.
Now Playing: Science for the People

#495 Earth Science in Space
Some worlds are made of sand. Some are made of water. Some are even made of salt. In science fiction and fantasy, planet can be made of whatever you want. But what does that mean for how the planets themselves work? When in doubt, throw an asteroid at it. This is a live show recorded at the 2018 Dragon Con in Atlanta Georgia. Featuring Travor Valle, Mika McKinnon, David Moscato, Scott Harris, and moderated by our own Bethany Brookshire. Note: The sound isn't as good as we'd hoped but we love the guests and the conversation and we wanted to...